Drug Safety : ADR Category 2
Cytotoxic t-lymphocyte antigen 4 inhibitors/Programmed cell death 1 receptor antagonists
Unknown adverse event: 4 case reports Release Date: 31 Dec 2025 Update Date: 31 Dec 2025
Price :
$20
*